Skip to content
DraconiticResearch
Search Sources API
210,418 studies31 sourcesUpdated 37 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Mapping existing hospital-based cancer prevention pathways in Europe: insights from EUnetCCC
    D Perrone, A Sabatelli, E Giacobini +7
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  2. Lymphatic Microvascular Density, Lymphatic Invasion and Endothelial Cell Proliferation as Prognostic Biomarkers in Cutaneous Melanoma: A Systematic Review and Evidence Map
    Victor Cristian Dumitrascu, Amalia Raluca Ceaușu, Mihai Mitulețu +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Context-Dependent Spatial and Functional Roles of CD44 Across Pancreatic Ductal Adenocarcinoma States
    Bin Fu, Yingying Tan, Yaxin Chen +6
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  4. Immune Cell Engagers and “Masking Immunotherapy” for Solid Tumors: Focus on Head and Neck Cancers
    Giuseppe Nardo, Deborah Lenoci, Marta Lucchetta +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Targeting Peripheral T-Cell Lymphomas with Chimeric Antigen Receptor Therapy: Mechanistic Challenges, Clinical Landscape and Future Engineering Perspectives
    Ruxandra Irimia, Pier Paolo Piccaluga
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  6. Salvage Surgery with Intraoperative Electron Radiation Therapy for Recurrent or Persistent Head and Neck Cancer After Prior Radiotherapy
    Ahmed N. Elguindy, Sujith Baliga, Brett G. Klamer +21
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  7. The SP4–NUPR1–SELM Axis Promotes Glycolytic Reprogramming and Stemness-Associated Phenotypes in Bladder Cancer
    Hannuo Deng, Rui Sun, Guangming He +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  8. FragMIL: A Fragment-Token Multiple-Instance Learning Framework for Cancer Detection from Cell-Free DNA Fragmentomics
    Tien-Dung Bui, Yung-Feng Lin, Mai-Hanh Nguyen +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  9. Infectious Complications and Toxicities of the Teclistamab Plus Daratumumab Combination in Relapsed or Refractory Multiple Myeloma: A Disproportionality and Drug–Interaction Analysis of the FDA Adverse Event Reporting System
    Carmel Awadallah, Sohaib Irfan, Al-Ola Abdallah +1
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  10. Psychosocial Interventions in Cancer Survivorship: A Rapid Scoping Review of the Recent PubMed-Indexed Literature
    Anita Müller, Selma Barbot, Morgan Dondin +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  11. Optimized Feature Engineering and Machine Learning Approaches for Early Prediction of Renal Cell Carcinoma
    Neha Chankhore, Deepali Vora, Paolo Barsocchi +1
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  12. Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction
    Chanyi Jiang, Xiankun Liu, Yijun Yu +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  13. Identification of Urokinase Plasminogen Activator Receptor (uPAR)-Binding Peptides Using Phage Display: Strategy and Downstream Validation
    Ane Beth Sloth, Ida Melisa Dawoodi, Tuule Treiberg +8
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  14. miR-98-5p, miR-130a-3p, and miR-1246 Profiling in Tissue and Liquid Biopsies of Patients with Hepatocellular Carcinoma
    Martina Maffezzoni, Ilaria Grossi, Iulia Andreea Pelisenco +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  15. Lung Multidisciplinary Team Decision-Making Challenges in Perioperative NSCLC: Borderline Resectability and Discordant Responses Through the Lens of Real-World Scenarios
    Diego Luigi Cortinovis, Stefania Canova, Maria Ida Abbate +12
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  16. The Evolution of Oligometastatic Pancreatic Ductal Adenocarcinoma: From Anatomic Description to Biologically Informed Patient Selection
    Kshitij S. Gaur, William A. Hall, Mandana Kamgar +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  17. Longitudinal Flow Cytometric Profiling of CAR-T and Endogenous T Cells Following CD19 CAR-T Therapy
    Sungyu Jee, Taewon Kang, Hyunjoo Bae +8
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  18. Association of HBsAg Positivity and HBV Reactivation in EGFR-Mutant Lung Adenocarcinoma Treated with EGFR-TKIs: A Retrospective Cohort Study
    Jiayi Sun, Jingwen Lin, Honglin Li +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  19. Cancer Cell Metabolic Reprogramming: Dietary, Pharmacological Strategies and Clinical Perspectives
    Nikolaos Xydas, Emmanouil Panagiotou, Vasileios Kassos +7
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  20. Clinical and Biological Correlates of Resistance and Relapse After CD19-Directed CAR T-Cell Therapy in Large B-Cell Lymphoma: A Structured Narrative Review
    Jean Silva de Souza Resende, Igor Samesima Giner, Maria Gabriela Custodio de Figueiredo +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  21. Baseline Host Biomarkers and Six-Month Sustained Drug-Free Status After Atezolizumab–Bevacizumab for Hepatocellular Carcinoma: Exploratory Clinical Stratification Using PAN-DF Score
    Chikara Iino, Tamami Abe, Kei Endo +24
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  22. Convolutional, State-Space and Transformer Liver-Tumor Segmentation Models Trained on Hepatocellular Carcinoma Fail on the Same External Cases: Lesion Size Outweighs Architecture in Cross-Dataset Generalization
    Hüseyin Kutlu, Cemil Çolak, Sami Akbulut
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  23. Selection Instability and External Performance of Transcriptomic Models Beyond Age, Sex and Stage in Resected Lung Adenocarcinoma
    Zhihao Lei, Chenxi Zou, Wei Zhao
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  24. MTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches
    Susana Cedres, Laura Masfarre, Ilaria Priano +14
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. Prediction Models for Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
    Yun Luo, Youping Ding, Wei Liu +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC